(Includes activity from prior to launch to three years post-launch)
This category focuses on programmes supporting the introduction of new products or devices, major line extensions and significant new indications which bring new choices for patients. Launches may be local, regional, national, multi-national or global. Products previously introduced in other geographies are eligible for submission as relating to a new geography.
However, entries may be submitted to this category only once per geography for a given product, line extension or new indication. Detail should be given of pre-launch activities, wherever relevant.
The judges will be looking for:
- First-class strategic thinking, taking customer insights to help define SMART objectives and drive the overall strategy
- Robust implementation of the defined strategy, with the right objective measures to demonstrate success but also to allow for adaptation and change if needed.
- Adaptation and learning as necessitated, where relevant
Products launched in the two-year period between July 2023 and June 2025 are eligible.

